You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 1, olive capsules marked MSOD 120.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsule, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 2, pink capsules marked MSOD 90.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 3, brown capsules marked MSOD 60.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 4, light blue capsules marked MSOD 30.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 1, olive capsules marked MSOD 120.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsule, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 2, pink capsules marked MSOD 90.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 3, brown capsules marked MSOD 60.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
MS MONO capsules are indicated for the management of severe pain where:
other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
the pain is opioid-responsive, and
requires daily, continuous, long-term treatment.
MS MONO capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances.
MS MONO capsules are not indicated as an as-needed (PRN) analgesia.
Hard gelatin capsules, containing white to off white multiparticulates 0.25 to 1.8mm in diameter, printed in black ink. Size 4, light blue capsules marked MSOD 30.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
